The American Academy of Pediatrics has quietly rewritten its official patient guidance on giving children melatonin, and the update, revised on HealthyChildren.org as recently as January 22, 2026, is considerably more conservative than what most families are already doing at bedtime.
The new guidance tells parents to start at 0.5 to 1 milligram, not the 3, 5, or 10 milligram gummies that line most drugstore shelves, and says most children who respond to melatonin at all don’t need more than 3 to 6 milligrams total. It also reframes melatonin itself: not as a nightly sleep aid, but as a short-term bridge to use only “after a discussion with your pediatrician” and only once consistent bedtime habits are already in place.
That’s a meaningfully higher bar than current practice. In a 2023 survey from the American Academy of Sleep Medicine, 46% of parents said they had given melatonin to a child under 13, and 30% had given it to a teenager — with no requirement in most households that a pediatrician sign off first, and no consistent standard for dose.
Why the tighter line now
Part of the problem the AAP is responding to is that melatonin sold in the U.S. is a supplement, not a drug, so the amount on the label doesn’t reliably match what’s in the bottle. The AASM’s own health advisory on melatonin in children and adolescents found products testing anywhere from less than half to more than four times their labeled dose, and it now recommends parents look specifically for the USP Verified Mark, a manufacturing-standard seal, before buying.
Both organizations are also pushing back on the idea that melatonin fixes a sleep problem on its own. The AASM advisory states plainly that “many sleep problems can be better managed with a change in schedules, habits, or behaviors rather than taking melatonin,” and the updated AAP guidance frames dosing itself as secondary to that behavioral work, not a shortcut around it.
What changed, in practice
For parents currently reaching for whatever dose is on the shelf, the new guidance narrows things on three fronts: a lower starting dose than most commercial gummies contain, an explicit ceiling most children shouldn’t need to cross, and a requirement to loop in a pediatrician before melatonin becomes routine rather than after it already is. None of it bans melatonin outright. It just treats a supplement many households have been giving out casually as something closer to a monitored, short-term tool — which is a real shift from how it’s been marketed, and sold, for years.
